Skip to Content

Haemophilus b conjugate (prp-omp) vaccine Pregnancy and Breastfeeding Warnings

Haemophilus b conjugate (prp-omp) vaccine is also known as: Liquid PedvaxHIB

Medically reviewed by Drugs.com. Last updated on Nov 28, 2019.

Haemophilus b conjugate (prp-omp) vaccine Pregnancy Warnings

Animal studies are not available. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Safety has not been established. This vaccine is only approved for use in young children.

US FDA pregnancy category: C

See references

Haemophilus b conjugate (prp-omp) vaccine Breastfeeding Warnings

This vaccine is only approved for use in young children.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Company Inc, West Point, PA.

References for breastfeeding information

  1. "Product Information. Liquid PedvaxHIB (haemophilus b conjugate (PRP-OMP) vaccine)." Merck & Company Inc, West Point, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.